Myeloid dendritic cells are primed in allergic asthma for thymic stromal lymphopoietin-mediated induction of Th2 and Th9 responses

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 69, Issue 8, 2014, Pages 1068-1076

  Froidure, A ^a,b   Shen, C ^a   Gras, D ^c   Van Snick, J ^d   Chanez, P ^c,e   Pilette, C ^a,b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c INSERM   (France)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

Author keywords

asthma; interleukin 9; myeloid dendritic cells; Th9; thymic stromal lymphopoietin

Indexed keywords

ALLERGEN; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 9; LIPOPOLYSACCHARIDE; OX40 LIGAND; THYMIC STROMAL LYMPHOPOIETIN; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR PU 1; TRANSFORMING GROWTH FACTOR BETA1; ARTHROPOD PROTEIN; CRLF2 PROTEIN, HUMAN; CYSTEINE PROTEINASE; CYTOKINE; CYTOKINE RECEPTOR; DERMATOPHAGOIDES PTERONYSSINUS ANTIGEN P 1; HOUSE DUST ALLERGEN;

ALLERGIC ASTHMA; ARTICLE; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; COCULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RESPONSE; DERMATOPHAGOIDES PTERONYSSINUS; FLUORESCENCE ACTIVATED CELL SORTING; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; MIXED LYMPHOCYTE REACTION; MYELOID DENDRITIC CELL; PHENOTYPE; POSITIVE FEEDBACK; PRIORITY JOURNAL; TH2 CELL; TH9 CELL; UPREGULATION; ANTAGONISTS AND INHIBITORS; ASTHMA; CASE CONTROL STUDY; DENDRITIC CELL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, DERMATOPHAGOIDES; ARTHROPOD PROTEINS; ASTHMA; CASE-CONTROL STUDIES; CYSTEINE ENDOPEPTIDASES; CYTOKINES; DENDRITIC CELLS; GENE EXPRESSION; HUMANS; OX40 LIGAND; RECEPTORS, CYTOKINE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; UP-REGULATION;

EID: 84904040636     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12435     Document Type: Article

References (35)

1. Simpson TR, Quezada SA, Allison JP,. Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS). Curr Opin Immunol 2010; 22: 326-332.
2. Akbari O, Stock P, Singh AK, Lombardi V, Lee WL, Freeman GJ, et al. PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions. Mucosal Immunol 2010; 3: 81-91.
3. Dua B, Smith S, Kinoshita T, Imaoka H, Gauvreau G, O'Byrne P,. Myeloid dendritic cells type 2 in allergic asthma. Allergy 2013; 68: 1322-1326.
4. Farrell E, O'Connor TM, Duong M, Watson RM, Strinich T, Gauvreau GM, et al. Circulating myeloid and plasmacytoid dendritic cells after allergen inhalation in asthmatic subjects. Allergy 2007; 62: 1139-1145.
5. Dua B, Watson RM, Gauvreau GM, O'Byrne PM,. Myeloid and plasmacytoid dendritic cells in induced sputum after allergen inhalation in subjects with asthma. J Allergy Clin Immunol 2010; 126: 133-139.
6. Angkasekwinai P, Park H, Wang YH, Wang YH, Chang SH, Corry DB, et al. Interleukin 25 promotes the initiation of proallergic type 2 responses. J Exp Med 2007; 204: 1509-1517.
7. Corrigan CJ, Wang W, Meng Q, Fang C, Eid G, Caballero MR, et al. Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses. J Allergy Clin Immunol 2011; 128: 116-124.
8. Eiwegger T, Akdis CA,. IL-33 links tissue cells, dendritic cells and Th2 cell development in a mouse model of asthma. Eur J Immunol 2011; 41: 1535-1538.
9. Ying S, O'Connor B, Ratoff J, Meng Q, Mallett K, Cousins D, et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol 2005; 174: 8183-8190.
10. Ito T, Wang YH, Duramad O, Hori T, Delespesse GJ, Watanabe N, et al. TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand. J Exp Med 2005; 202: 1213-1223.
11. Liu YJ,. Thymic stromal lymphopoietin and OX40 ligand pathway in the initiation of dendritic cell-mediated allergic inflammation. J Allergy Clin Immunol 2007; 120: 238-244.
12. Charbonnier AS,. Der p 1-pulsed myeloid and plasmacytoid dendritic cells from house dust mite-sensitized allergic patients dysregulate the T cell response. J Leukoc Biol 2003; 73: 91-99.
13. Hammad H,. Th2 polarization by Der p 1-pulsed monocyte-derived dendritic cells is due to the allergic status of the donors. Blood 2001; 98: 1135-1141.
14. Pilette C, Jacobson MR, Ratajczak C, Detry B, Banfield G, VanSnick J, et al. Aberrant dendritic cell function conditions Th2-cell polarization in allergic rhinitis. Allergy 2013; 68: 312-321.
15. Yao W, Zhang Y, Jabeen R, Nguyen ET, Wilkes DS, Tepper RS, et al. Interleukin-9 is required for allergic airway inflammation mediated by the cytokine TSLP. Immunity 2013; 38: 360-372.
16. Kaplan MH,. Th9 cells: differentiation and disease. Immunol Rev 2013; 252: 104-115.
17. Soroosh P, Doherty TA,. Th9 and allergic disease. Immunology 2009; 127: 450-458.
18. Parker JM, Oh CK, LaForce C, Miller SD, Pearlman DS, Le C, et al. Safety profile and clinical activity of multiple subcutaneous doses of MEDI-528, a humanized anti-interleukin-9 monoclonal antibody, in two randomized phase 2a studies in subjects with asthma. BMC Pulm Med 2011; 11: 14.
19. National Heart Lung and Blood Institute. Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention. Rev. 2002 edn. Bethesda, MD: U.S. Department of Health and Human Services, Public Health Service, 2002.
20. Gras D, Bourdin A, Vachier I, de Senneville L, Bonnans C, Chanez P,. An ex vivo model of severe asthma using reconstituted human bronchial epithelium. J Allergy Clin Immunol 2012; 129: 1259-1266.
21. Chen AI, McAdam AJ, Buhlmann JE, Scott S, Lupher ML Jr, Greenfield EA, et al. Ox40-ligand has a critical costimulatory role in dendritic cell: T cell interactions. Immunity 1999; 11: 689-698.
22. He JQ, Hallstrand TS, Knight D, Chan-Yeung M, Sandford A, Tripp B, et al. A thymic stromal lymphopoietin gene variant is associated with asthma and airway hyperresponsiveness. J Allergy Clin Immunol 2009; 124: 222-229.
23. Harada M, Hirota T, Jodo AI, Hitomi Y, Sakashita M, Tsunoda T, et al. Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma. Am J Respir Cell Mol Biol 2011; 44: 787-793.
24. Shikotra A, Choy DF, Ohri CM, Doran E, Butler C, Hargadon B, et al. Increased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma. J Allergy Clin Immunol 2012; 129: 104-111.
25. Corrigan CJ, Jayaratnam A, Wang Y, Liu Y, de Waal Malefyt R, Meng Q, et al. Early production of thymic stromal lymphopoietin precedes infiltration of dendritic cells expressing its receptor in allergen-induced late phase cutaneous responses in atopic subjects. Allergy 2009; 64: 1014-1022.
26. Zhang F, Huang G, Hu B, Song Y, Shi Y,. A soluble thymic stromal lymphopoietin (TSLP) antagonist, TSLPR-immunoglobulin, reduces the severity of allergic disease by regulating pulmonary dendritic cells. Clin Exp Immunol 2011; 164: 256-264.
27. Xiao X, Balasubramanian S, Liu W, Chu X, Wang H, Taparowsky EJ, et al. OX40 signaling favors the induction of T(H)9 cells and airway inflammation. Nat Immunol 2012; 13: 981-990.
28. Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, Buer J, et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008; 9: 1341-1346.
29. Chen ZG, Zhang TT, Li HT, Chen FH, Zou XL, Ji JZ, et al. Neutralization of TSLP inhibits airway remodeling in a murine model of allergic asthma induced by chronic exposure to house dust mite. PLoS One 2013; 8: e51268.
30. Cheng DT, Ma C, Niewoehner J, Dahl M, Tsai A, Zhang J, et al. Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma. J Allergy Clin Immunol 2013; 132: 455-462.
31. Erpenbeck VJ, Hohlfeld JM, Volkmann B, Hagenberg A, Geldmacher H, Braun A, et al. Segmental allergen challenge in patients with atopic asthma leads to increased IL-9 expression in bronchoalveolar lavage fluid lymphocytes. J Allergy Clin Immunol 2003; 111: 1319-1327.
32. Jones CP, Gregory LG, Causton B, Campbell GA, Lloyd CM,. Activin A and TGF-beta promote T(H)9 cell-mediated pulmonary allergic pathology. J Allergy Clin Immunol 2012; 129: 1000-1010.
33. Ohno T, Morita H, Arae K, Matsumoto K, Nakae S,. Interleukin-33 in allergy. Allergy 2012; 67: 1203-1214.
34. Gregory LG, Jones CP, Walker SA, Sawant D, Gowers KH, Campbell GA, et al. IL-25 drives remodelling in allergic airways disease induced by house dust mite. Thorax 2013; 68: 82-90.
35. Moller GM, Overbeek SE, Van Helden-Meeuwsen CG, Van Haarst JM, Prens EP, Mulder PG, et al. Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy 1996; 26: 517-524.